Determining the efficacy of mycotoxin mitigators: In vitro vs In vivo

14-10-2019 | |
Photo: Alltech
Photo: Alltech
Commercial marketing of feed additives to prevent mycotoxicosis began about 40 years ago and is now a major industry. However, the challenge for suppliers has been proving product efficacy. Most methodology includes in vitro binding assays with individual purified mycotoxins, but extrapolating in vitro results to actual field conditions may not prove accurate. As a result, a more accurate method for testing product efficiency may be through in vivo studies. Most methodology includes in vitro bi


Get full access to all stories on Dairy Global

This Premium article is exclusively available for subscribers

Obtain insights from exclusive interviews

Dive into articles covering trending industry topics

Get a glimpse into dairy farms worldwide

All the news is brought to you by experienced editors and experts from around the world

Redacteur 1

Zana
van Dijk

Redacteur 2

Chris
Mccullough

Redacteur 3

Samaneh
Azarpajouh

Content
Sponsored Content Contributions from various companies

Webinar-2026-CID-lines